The Endometriosis Health Profile (Ehp) – A Case Study of Successful Epro Collaboration

Abstract

A517 had "symptoms" as a primary endpoint; a drug for rheumatoid arthritis (RA) had "functioning" as its lead secondary endpoint; the remaining six drugs (for pulmonary arterial hypertension (PAH), Crohn's Disease, smoking cessation, Myasthenia Gravis, asthma, and overactive bladder) had "HRQOL", "symptoms, and "functioning" as minor secondary endpoints. Three drugs-indicated for PAH, seizure, and RA-had PRO claims in their labels. ConClusions: Although not yet prominent in Japan, PROs are used in drug clinical trials and label claims. Symptoms, Quality of Life, and Functioning are the most common PROs used. PIH76 ComParIng tHe equIvalenCe of eq-5d-5l aCross dIfferent modes of admInIstratIon